Literature DB >> 3106360

Identification and characterization of two functional domains in cytochrome P-450BM-3, a catalytically self-sufficient monooxygenase induced by barbiturates in Bacillus megaterium.

L O Narhi, A J Fulco.   

Abstract

In a previous publication (Narhi, L. O. and Fulco, A. J. (1986) J. Biol. Chem. 261, 7160-7169) we described the characterization of a soluble 119,000-dalton P-450 cytochrome (P-450BM-3) that was induced by barbiturates in Bacillus megaterium. This single polypeptide contained 1 mol each of FAD and FMN/mol of heme and, in the presence of NADPH and O2, catalyzed the oxygenation of long-chain fatty acids without the aid of any other protein. We have now utilized limited trypsin proteolysis in the presence of substrate to cleave P-450BM-3 into two polypeptides (domains) of about 66,000 and 55,000 daltons. The 66-kDa domain contains both FAD and FMN but no heme, reduces cytochrome c in the presence of NADPH, and is derived from the C-terminal portion of P-450BM-3. The 55-kDa domain is actually a mixture of three discrete peptides (T-I, T-II, and T-III) separable by high performance liquid chromatography. All three contain heme and show a P-450 absorption peak in the presence of CO and dithionite. The major component, T-I (Mr = 55 kDa), binds fatty acid substrate and has an N-terminal amino acid sequence identical to that of intact P-450BM-3, an indication that this domain constitutes the N-terminal portion of the 119-kDa protein. T-II (54 kDa) is the same as T-I except that it is missing the first nine N-terminal amino acids and does not bind substrate. T-III (Mr = 53.5 kDa) has lost the first 15 N-terminal residues and does not bind substrate. Since trypsin digestion of P-450BM-3 carried out in the absence of substrate yields T-II and T-III but no T-I, it appears that 1 or more residues of the first nine N-terminal amino acids of this protein are intimately involved in substrate binding. Although both the heme- and flavin-containing tryptic peptides retain their original half-reactions, fatty acid monooxygenase activity cannot be reconstituted after proteolysis, and the two domains, once separated, show no affinity for each other. In most respects, the reductase domain of P-450BM-3 more closely resembles the mammalian microsomal P-450 reductases than it does any known bacterial protein.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106360

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Domains of the catalytically self-sufficient cytochrome P-450 BM-3. Genetic construction, overexpression, purification and spectroscopic characterization.

Authors:  J S Miles; A W Munro; B N Rospendowski; W E Smith; J McKnight; A J Thomson
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

2.  Chemoenzymatic synthesis and antileukemic activity of novel C9- and C14-functionalized parthenolide analogs.

Authors:  Vikas Tyagi; Hanan Alwaseem; Kristen M O'Dwyer; Jessica Ponder; Qi Ying Li; Craig T Jordan; Rudi Fasan
Journal:  Bioorg Med Chem       Date:  2016-06-16       Impact factor: 3.641

3.  Functional characterisation of an engineered multidomain human P450 2E1 by molecular Lego.

Authors:  Michael Fairhead; Silva Giannini; Elizabeth M J Gillam; Gianfranco Gilardi
Journal:  J Biol Inorg Chem       Date:  2005-11-09       Impact factor: 3.358

4.  Thermal inactivation of the reductase domain of cytochrome P450 BM3.

Authors:  Arvind P Jamakhandi; Brandon C Jeffus; Vandana R Dass; Grover P Miller
Journal:  Arch Biochem Biophys       Date:  2005-07-15       Impact factor: 4.013

5.  Evolutionary history of a specialized p450 propane monooxygenase.

Authors:  Rudi Fasan; Yergalem T Meharenna; Christopher D Snow; Thomas L Poulos; Frances H Arnold
Journal:  J Mol Biol       Date:  2008-06-28       Impact factor: 5.469

6.  Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.

Authors:  Joshua N Kolev; Kristen M O'Dwyer; Craig T Jordan; Rudi Fasan
Journal:  ACS Chem Biol       Date:  2013-11-08       Impact factor: 5.100

7.  Crystal structure of albaflavenone monooxygenase containing a moonlighting terpene synthase active site.

Authors:  Bin Zhao; Li Lei; Dmitry G Vassylyev; Xin Lin; David E Cane; Steven L Kelly; Hang Yuan; David C Lamb; Michael R Waterman
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

8.  Identification of the domains of neuronal nitric oxide synthase by limited proteolysis.

Authors:  P N Lowe; D Smith; D K Stammers; V Riveros-Moreno; S Moncada; I Charles; A Boyhan
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

9.  Probing the structure of the linker connecting the reductase and heme domains of cytochrome P450BM-3 using site-directed mutagenesis.

Authors:  S Govindaraj; T L Poulos
Journal:  Protein Sci       Date:  1996-07       Impact factor: 6.725

10.  Exploring the electron transfer properties of neuronal nitric-oxide synthase by reversal of the FMN redox potential.

Authors:  Huiying Li; Aditi Das; Hiruy Sibhatu; Joumana Jamal; Stephen G Sligar; Thomas L Poulos
Journal:  J Biol Chem       Date:  2008-10-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.